Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 18/20 | 0.55 |
| ▸ | CA1 | P00915 | 12/20 | 0.55 |
| ▸ | CA9 | Q16790 | 7/20 | 0.55 |
| ▸ | CA12 | O43570 | 5/20 | 0.55 |
| ▸ | CA5A | P35218 | 4/20 | 0.55 |
| ▸ | CA7 | P43166 | 4/20 | 0.55 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.55 |
| ▸ | CA4 | P22748 | 3/20 | 0.55 |
| ▸ | CA6 | P23280 | 3/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.55 |
| ▸ | CA3 | P07451 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24478395 | 1.00 | CA2 (0.55) | CA2CA1CA9CA12CA5A | |
| SCHEMBL24478028 | 0.85 | CA2 (0.52) | CA2CA1CA9CA12CA5A | |
| SCHEMBL13728450 | 0.82 | CA2 (0.69) | CA2CA1CA9CA12CA5A | |
| SCHEMBL21550042 | 0.81 | GAA (0.40) | CA2CA1CA9CA12CA5A | |
| SCHEMBL1808225 | 0.81 | CA2 (0.52) | CA2CA1CA9CA12CA5A | |
| SCHEMBL2224639 | 0.81 | CA2 (0.60) | CA2CA1CA9CA12CA5A | |
| SCHEMBL3102634 | 0.79 | CA2 (0.71) | CA2CA1CA9CA12CA5A | |
| SCHEMBL1808162 | 0.79 | CA2 (0.50) | CA2CA1CA9CA12CA5A | |
| SCHEMBL1802517 | 0.79 | CA2 (0.56) | CA2CA1CA9CA12CA5A | |
| SCHEMBL30048667 | 0.78 | CA2 (0.57) | CA2CA1CA9CA12CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12467928-B2 | N-terminal modifier agents and binders for treating and analyzing peptides | DF PEPTIDE ACQUISITION LLC | 2025-11-11 | — | — | US | disclosed |
| US-20240377408-A1 | N-TERMINAL MODIFIER AGENTS AND BINDERS FOR TREATING AND ANALYZING PEPTIDES | DF PEPTIDE ACQUISITION LLC | 2024-11-14 | — | — | US | disclosed |
| EP-4251630-A1 | SULFONYL UREA NLRP3 INFLAMMASOME INHIBITORS | Venatorx Pharmaceuticals, Inc. (US) | 2023-10-04 | — | — | EP | disclosed |
| CN-116710461-A | Sulfonylurea NLRP3 inflammation corpuscle inhibitor | 维纳拓尔斯制药公司 | 2023-09-05 | — | — | CN | disclosed |
| WO-2022115417-A1 | SULFONYL UREA NLRP3 INFLAMMASOME INHIBITORS | VenatoRx Pharmaceuticals, Inc. (US) | 2022-06-02 | — | — | WO | disclosed |